In the News
Cardiologists call for routine measurement of C-reactive protein
The American College of Cardiology issued a new scientific statement highlighting that inflammation strongly predicts risk of cardiovascular disease events and is best assessed by C-reactive protein levels.
Increase in gabapentin dispensing highlights need for awareness of adverse effects
Gabapentin was the fifth most prescribed medication in the U.S. in 2024, having increased from 79.5 prescriptions per 1,000 persons in 2010 to 177.6 per 1,000 persons in 2024.
MKSAP Quiz: Follow-up for amenorrhea
A 32-year-old woman is evaluated at a follow-up visit for amenorrhea. She underwent menarche at age 12 years and had regular monthly menses until 4 months ago, when she experienced cessation of menses. Following a physical exam and lab studies, what is the most appropriate treatment?
Guideline offers recommendations on biologic management of severe asthma in adults
Adult patients with moderate to severe allergic asthma and one or more exacerbations per year requiring oral corticosteroids should receive omalizumab or dupilumab, while patients with two or more exacerbations per year or any severe exacerbation requiring hospitalization should receive dupilumab over omalizumab, according to the American College of Chest Physicians.
2026-2027 committee appointments survey open for applications
To be considered for the 2026-2027 committee appointments cycle, survey responses must be submitted by Oct. 15.
Vote for your favorite entry
I.M. Matters Weekly from ACP's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.